(Q44890236)

English

Effect of single oral administration of YM598, a novel selective endothelin ETA receptor antagonist, on blood pressure in normotensive and hypertensive rats

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Effect of single oral administration of YM598, a novel selective endothelin ETA receptor antagonist, on blood pressure in normotensive and hypertensive rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Hironori Yuyama

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Rie Sonoda

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Kumiko Shibasaki

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Akira Fujimori

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Katsumi Sudoh

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Masao Sasamata

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Keiji Miyata

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

27-34

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Cloning and expression of a cDNA encoding an endothelin receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Effect of an endothelin antagonist on hemodynamic responses to angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Effects of chronia excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Mechanical properties of mesenteric resistance arteries from Dahl salt-resistant and salt-sensitive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Acute hypotensive response to nifedipine added to prazosin in treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Role of endothelin in mediating the attenuated renal hemodynamics in Dahl salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Pathophysiology of endothelin in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Endothelin in hypertension: a role for receptor antagonists?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Marked reduction of mortality in salt-loaded Dahl salt-sensitive rats by the new, selective endothelin ETA receptor antagonist, J-105859.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Development of a strain of spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Combined alpha adrenoceptor antagonism and calcium channel blockade in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Molecular characterization of endothelin receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Differential sensitivity of Dahl salt-sensitive and Dahl salt-resistant rats to the hypotensive action of acute nifedipine administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.03.004

7 January 2021

Identifiers

10.1016/J.VPH.2004.03.004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44890236&oldid=2055838982"